NSE · AHCL
Anlon Healthcare Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹31 Cr with net profit ₹5 Cr — a 15.49% net margin, versus 16.56% the period before.
Shareholding
As of 2026-06-30
- Promoter52.68%
- Public44.43%
- FII1.67%
- DII1.22%
34,671 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.21× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ST-ASM · ASM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Chemicals · ranked #61 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹1,72,067 Cr | 86.4 | 27.41 | 26.72% | 17.54% |
| Pidilite Industries Ltd. | ₹1,57,955 Cr | 59.64 | 14.58 | 22.61% | 17.2% |
| SRF Ltd. | ₹75,514 Cr | 33.7 | 5.38 | 13.07% | 13.01% |
| Linde India Limited | ₹51,895 Cr | 94.97 | 12.16 | 12.87% | 20.59% |
| Gujarat Fluorochemicals Ltd. | ₹49,810 Cr | 80.64 | 6.37 | 7.13% | 11.41% |
| Navin Fluorine International Ltd. | ₹42,276 Cr | 53.16 | 10.64 | 16.69% | 21.73% |
| Godrej Industries Ltd. | ₹38,367 Cr | 31.36 | 3.43 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹32,994 Cr | 41.28 | 7.01 | 15.96% | 16.07% |
| Deepak Nitrite Ltd. | ₹21,924 Cr | 27.68 | 3.76 | 9.43% | 9.13% |
| Aether Industries Limited | ₹21,572 Cr | 89.89 | 8.78 | 8.94% | 19.11% |
| Anlon Healthcare Limited(this company) | ₹1,145 Cr | 35.92 | 4.98 | 12.39% | 13.98% |
AI analysis
AI-generated · google/gemini-2.5-flashAnlon Healthcare Limited (AHCL) is listed in the Chemicals sector with a market capitalization of Rs 817 Cr. The company reported an EPS of 0.54 and a PE ratio of 28.46. Its book value stands at 4.33, with a Return on Equity (ROE) of 12.39% and a Return on Capital Employed (ROCE) of 16.89%. The debt-to-equity ratio is 1.46. For the quarter ended March 2026, the company recorded revenue of Rs 50.89 Cr and a net profit of Rs 10.5 Cr.
Positives
- +The Return on Capital Employed (ROCE) was 16.89%, indicating efficient use of capital.
- +Promoter shareholding in March 2026 was 52.68%, representing a majority stake.
- +No shares were pledged by promoters, with promoter pledge at 0%.
Negatives
- −The profit margin is 0%, indicating no profitability from operations based on the provided figure.
- −The debt-to-equity ratio is 1.46, which is relatively high.
- −Promoter shareholding significantly decreased from 70.26% in October 2024 to 52.68% in March 2026.
- −The company reported a negative net profit of Rs -2.49 Cr in December 2024.
- −No dividend yield was reported (0%).
Financial Performance
In the financial year ending March 2025, Anlon Healthcare Limited reported total revenue of Rs 120.45 Cr and a net profit of Rs 20.52 Cr. Quarterly revenue for March 2026 was Rs 50.89 Cr, with a net profit of Rs 10.5 Cr. This follows a previous quarter in December 2025 where revenue was Rs 35.58 Cr and net profit was Rs 5.15 Cr.
Profitability & Returns
The company's Return on Equity (ROE) is 12.39%, while the Return on Capital Employed (ROCE) is 16.89%. The earnings per share (EPS) for the most recent available annual period (Mar 2025) was Rs 6.37. The profit margin for the company is 0% based on the provided data.
Balance Sheet
Anlon Healthcare Limited has a debt-to-equity ratio of 1.46, indicating a significant reliance on debt financing. The book value per share is Rs 4.33. No further detailed balance sheet figures are available in the provided data.
Ownership & Pledges
Public shareholding stands at 42.40%. Total institutional holding is 4.92%. There are no promoter shares pledged, with promoter pledge at 0%.
Data as of — price: 2026-09-17 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.